LSG (Longitudinal Sleeve Gastrectomy) resolves T2DM (Type II Diabetes Mellitus) better than RYGB (Roux-en-Y Gastric Bypass) for male patients
Boston, MA (October 2015) – At the 31st Annual ASMBS Obesity Week Meeting, Dr. Ragui Sadek of Bristol-Myers Squibb Children’s Hospital and Advanced Surgical and Bariatrics presented his research on the optimal procedure for male patients seeking type II diabetes mellitus resolution to the members of the ASMBS (American Society for Metabolic and Bariatric Surgery).
“Type II diabetes mellitus (T2DM) is a condition that affects one in six adults worldwide and is defined by the improper use of insulin dually notes as insulin resistance, or reduction of insulin production,” states Dr. Sadek. “As a result, patients experience hyperglycemia and are unable to properly manage their blood glucose levels without prescribed medication.”
The purpose of Dr. Ragui Sadek’s research was to analyze and compare the resolution of T2DM with respect to 562 male LSG and 113 RYGB patients, as well as a further expansion of the comparative rate of diabetes resolution in Male (562) versus Females (467) with the LSG procedure.
Dr. Sadek’s research found that Laparoscopic Sleeve Gastrectomy is a viable option for morbidly obese patients seeking type II diabetes resolution. “LSG (Longitudinal Sleeve Gastrectomy) resolves T2DM (Type II Diabetes Mellitus) better than RYGB (Roux-en-Y Gastric Bypass) for male patients” says Dr. Sadek in his presentation. He goes on to say that LSG resolves type II diabetes far better in male patients than female patients. “Ties to central fat loss in males, versus peripheral fat loss in females following LSG may be a possible cause for the differential resolution rates of type II diabetes in bariatric patients.”